No ways we should even consider any offers at this low market value. Valuation will progressively increase to reflect the pathway to commercialisation as we go. From now on, we should be able to attract new investors to fund the trials at higher share price.
Not advice, DYOR!
No ways we should even consider any offers at this low market...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 577 | $11.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.93 | 131 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |